Empyrean Capital Partners’s Elanco Animal Health ELAN Stock Holding History

Empyrean Capital Partners’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,045,167	Closed	-$20.5M	–	131
2022 Q2	$20.5M	Sell	1,045,167 -400,000	-28%	-$9.47M	0.65%	56
2022 Q1	$37.7M	Hold	1,445,167	–	–	0.83%	36
2021 Q4	$41M	Hold	1,445,167	–	–	1.09%	25
2021 Q3	$46.1M	Buy	1,445,167 +318,528	+28%	+$10.7M	1.02%	30
2021 Q2	$39.1M	Buy	+1,126,639	New	+$37.2M	0.89%	33
2019 Q2	–	Sell	-2,471,462	Closed	-$79.3M	–	85
2019 Q1	$79.3M	Buy	+2,471,462	New	+$76.1M	3.61%	6

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Empyrean Capital Partners's ELAN Position: Q3 2022 in Review

Empyrean Capital Partners sold out of Elanco Animal Health (ELAN) in Q3 2022, closing a stake of 1,045,167 shares — an estimated $20.5M sold.

Empyrean Capital Partners first reported a position in ELAN in Q1 2019 and held it in 6 quarters. The position peaked at $79.3M in Q1 2019. 419 funds tracked by Wall St. Rank hold ELAN as of Q3 2022.

Empyrean Capital Partners reported no remaining Elanco Animal Health position as of Q3 2022 after selling out during the quarter.
Empyrean Capital Partners sold 1,045,167 Elanco Animal Health shares in Q3 2022, an estimated $20.5M.
Empyrean Capital Partners first reported a position in Elanco Animal Health in Q1 2019 and held it in 6 quarters.
Empyrean Capital Partners's Elanco Animal Health position peaked at $79.3M in Q1 2019.
419 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2022.

Based on Empyrean Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.